Tag: Asia Pacific
TOT BIOPHARM and LEE’S PHARM Signed an Exclusive Licensing Agreement on Monoclonal Antibody Drug
TOT BIOPHARM Co Ltd. and LEE'S PHARMACEUTICAL HOLDINGS LIMITED jointly announced that LEE'S PHARM, through its wholly-owned subsidiary Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Limited has...
WuXi Biologics completes construction of Asia’s largest perfusion biologics manufacturing facility using disposable bioreactors
WuXi Biologics, a leading open-access R&D capability and technology platform company dedicated to biologics and a WuXi AppTec company, announced today the opening of...
Pfizer Bolsters China Presence With $350 Million Plant
Pfizer Inc. will invest $350 million in eastern China on a plant for biotechnology drugs, bolstering its presence in the world’s second largest pharmaceutical...
Key exhibitors and industry partners show strong support for MEDICAL MANUFACTURING ASIA 2016
3rd Manufacturing Processes for Medical Technology Exhibition and Conference sets the stage as the industry’s knowledge-information exchange platform ...
NATCO Pharma Limited receives USFDA tentative approval for Sorafenib Tablets, 200mg
Natco Pharma Limited announced that its marketing partner, Mylan Inc has received a tentative approval for its Abbreviated New Drug Application (ANDA) for Sorafenib...
Popular